166 related articles for article (PubMed ID: 24522333)
1. Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Psychopharmacology (Berl); 2014 Aug; 231(15):2933-40. PubMed ID: 24522333
[TBL] [Abstract][Full Text] [Related]
2. Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Synapse; 2015 Aug; 69(8):396-404. PubMed ID: 25963809
[TBL] [Abstract][Full Text] [Related]
3. Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia.
Frankel PS; Hoonakker AJ; Alburges ME; McDougall JW; McFadden LM; Fleckenstein AE; Hanson GR
J Pharmacol Exp Ther; 2011 Mar; 336(3):809-15. PubMed ID: 21131268
[TBL] [Abstract][Full Text] [Related]
4. Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.
Hanson GR; Hoonakker AJ; Robson CM; McFadden LM; Frankel PS; Alburges ME
J Pharmacol Exp Ther; 2013 Aug; 346(2):173-81. PubMed ID: 23685547
[TBL] [Abstract][Full Text] [Related]
5. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
6. Mephedrone alters basal ganglia and limbic neurotensin systems.
German CL; Hoonakker AH; Fleckenstein AE; Hanson GR
J Neurochem; 2014 Aug; 130(3):402-7. PubMed ID: 24678634
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic and dopamine D2 receptors mediate nicotine-induced changes in ventral tegmental area neurotensin system.
Alburges ME; Hoonakker AJ; Hanson GR
Eur J Pharmacol; 2007 Nov; 573(1-3):124-32. PubMed ID: 17689525
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
Alburges ME; Hoonakker AJ; Horner KA; Fleckenstein AE; Hanson GR
J Neurochem; 2011 May; 117(3):470-8. PubMed ID: 21323925
[TBL] [Abstract][Full Text] [Related]
9. Distinct responses of basal ganglia substance P systems to low and high doses of methamphetamine.
Hanson GR; Bush L; Keefe KA; Alburges ME
J Neurochem; 2002 Sep; 82(5):1171-8. PubMed ID: 12358764
[TBL] [Abstract][Full Text] [Related]
10. Response of limbic neurotensin systems to methamphetamine self-administration.
Hanson GR; Hoonakker AJ; Alburges ME; McFadden LM; Robson CM; Frankel PS
Neuroscience; 2012 Feb; 203():99-107. PubMed ID: 22245499
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
Hadlock GC; Baucum AJ; King JL; Horner KA; Cook GA; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2009 Apr; 329(1):169-74. PubMed ID: 19141713
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum.
Beauvais G; Jayanthi S; McCoy MT; Ladenheim B; Cadet JL
Brain Res; 2010 Mar; 1318():1-10. PubMed ID: 20059987
[TBL] [Abstract][Full Text] [Related]
13. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
Broening HW; Morford LL; Vorhees CV
Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
[TBL] [Abstract][Full Text] [Related]
14. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
Mohd-Yusof A; Veliz A; Rudberg KN; Stone MJ; Gonzalez AE; McDougall SA
Psychopharmacology (Berl); 2016 Mar; 233(5):893-903. PubMed ID: 26650612
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
Merchant KM; Bush LG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
[TBL] [Abstract][Full Text] [Related]
16. Contrasting responses by basal ganglia met-enkephalin systems to low and high doses of methamphetamine in a rat model.
Alburges ME; Keefe KA; Hanson GR
J Neurochem; 2001 Feb; 76(3):721-9. PubMed ID: 11158242
[TBL] [Abstract][Full Text] [Related]
17. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
Barrett AC; Miller JR; Dohrmann JM; Caine SB
Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
[TBL] [Abstract][Full Text] [Related]
18. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
19. Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats.
Brennan KA; Carati C; Lea RA; Fitzmaurice PS; Schenk S
Behav Pharmacol; 2009 Dec; 20(8):688-94. PubMed ID: 19881334
[TBL] [Abstract][Full Text] [Related]
20. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Lindgren HS; Ohlin KE; Cenci MA
Neuropsychopharmacology; 2009 Nov; 34(12):2477-88. PubMed ID: 19606087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
